DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/36f4c9/glaucoma_pipeline) has announced the addition of the "Glaucoma Pipeline Highlights - 2015" report to their offering.
The latest report Glaucoma Pipeline Highlights - 2015, provides most up-to-date information on key pipeline molecules in the global Glaucoma market. It covers emerging therapies for Glaucoma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Glaucoma pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Glaucoma pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Glaucoma pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which Glaucoma pipeline products will be launched in the US and Ex-US till 2017.
Key Topics Covered:
1. Glaucoma Pipeline by Stages
2. Glaucoma Pipeline by Drug Class
3. Glaucoma Pipeline by Company
4. Glaucoma Phase 3 Clinical Trial Insights
5. Glaucoma Phase 2 Clinical Trial Insights
6. Glaucoma Phase 1 Clinical Trial Insights
7. Glaucoma Preclinical Research Insights
8. Glaucoma Discovery Stage Insights
10. Research Methodology
For more information visit http://www.researchandmarkets.com/research/36f4c9/glaucoma_pipeline